These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31679825)

  • 1. In-Hospital Production of Medicines: Preparing for Disruption.
    Kalkman S; Arentshorst M; Hoekman J; Boon W; Uijtendaal E; van Thiel G; Moors E
    Trends Biotechnol; 2020 Oct; 38(10):1045-1047. PubMed ID: 31679825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital Compounding in Nigeria: A Review of Needs, Practice, and Suggestions for Pharmaceutical Dispensing Ciurriculum Development.
    Orubu ESF; Patani BO; Arhewoh MI
    Int J Pharm Compd; 2021; 25(6):475-481. PubMed ID: 34807842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magistral Compounding with 3D Printing: A Promising Way to Achieve Personalized Medicine.
    Beer N; Kaae S; Genina N; Sporrong SK; Alves TL; Hoebert J; De Bruin ML; Hegger I
    Ther Innov Regul Sci; 2023 Jan; 57(1):26-36. PubMed ID: 35943712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Conroy S
    Acta Paediatr; 2003 Apr; 92(4):408-10. PubMed ID: 12801103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Brion F; Nunn AJ; Rieutord A
    Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The possibilities of innovation of extemporaneous preparation in pharmacies in the Czech Republic].
    Sklenář Z; Horáčková K
    Ceska Slov Farm; 2012 Feb; 61(1-2):11-6. PubMed ID: 22536647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [City-hospital network and quality control of officinal preparations].
    Curti C; Gallice S; Lamy E; Rathelot P; Vanelle P
    Ann Pharm Fr; 2018 May; 76(3):242-247. PubMed ID: 29037451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
    Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
    Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Accidents linked to magistral medicines (author's transl)].
    Riboulet-Delmas G; Castot A; Efthymiou ML; Gaultier M
    Therapie; 1981; 36(3):375-9. PubMed ID: 7292419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ideas for the improvement of the quality of medicines prepared in the pharmacies].
    Hädicke M
    Pharm Prax; 1966; 4():103-4. PubMed ID: 5912129
    [No Abstract]   [Full Text] [Related]  

  • 11. Protein Quality Testing in the Era of Personalized Medicine.
    Doevendans E; Schellekens H
    J Pharm Sci; 2020 Oct; 109(10):2962-2968. PubMed ID: 32673626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Extent of Extemporaneous Preparation and Regulatory Framework of Extemporaneous Compounding in Latvia.
    Kiseļova O; Mauriņa B; Šidlovska V; Zvejnieks J
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31454896
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recommendations for the safety preparation of sterile medicines in medical wards].
    Martín de Rosales Cabrera AM; López Cabezas C; Pernía López MS; Dávila Pousa C; Vila Clérigues MN; Alonso Herreros JM; García Salom P; Lozano Blázquez A
    Farm Hosp; 2014 Jan; 38(1):57-64. PubMed ID: 24483861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
    Minghetti P; Pantano D; Gennari CG; Casiraghi A
    Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Outlook on the European and Italian Rules to Guarantee Magistral Formulas.
    Selmin F; Casiraghi A; Musazzi UM; Fortini M; Minghetti P
    Int J Pharm Compd; 2019; 23(1):6-12. PubMed ID: 30668530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increasing the amount and widening the choice of ready-made drugs in relation to drug preparation by prescription in the pharmacy].
    Kulesh KF; Shpak RS
    Farm Zh; 1970; 25(5):15-21. PubMed ID: 4928360
    [No Abstract]   [Full Text] [Related]  

  • 17. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of defects occurring during drug preparation in pharmacies of the South-Moravian region II].
    Strakosová L
    Cesk Farm; 1968 Jan; 17(1):23-7. PubMed ID: 5668236
    [No Abstract]   [Full Text] [Related]  

  • 19. The possibility of obtaining marketing authorization of orphan pharmaceutical compounding preparations: 3,4-DAP for Lambert-Eaton Myasthenic Syndrome.
    de Wilde S; de Jong MGH; Lipka AF; Guchelaar HJ; Schimmel KJM
    Eur J Pharm Sci; 2018 Mar; 114():24-29. PubMed ID: 29191521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.